Epidermal Growth Factor Receptor and K-ras Mutations in Patients With Stage III Non-Small Cell Lung Cancer
Study Information
Alliance Study ID: CALGB-150508
NCT Study ID (ClinicalTrials.gov): NCT00898924
Disease or Cancer Type: Lung Cancer & Mesothelioma
Alliance Study Chair: Pasi Janne, MD, PhD
Status: COMPLETED
Study Description
RATIONALE: Collecting and storing samples of tissue from patients with cancer to study in the laboratory may help doctors learn more about changes that may occur in DNA and identify biomarkers related to cancer.
PURPOSE: This laboratory study is looking at epidermal growth factor receptor mutations and k-ras oncogene mutations in patients with stage III non-small cell lung cancer.
Related Publications
For publications related to this and other clinical trials, visit the Alliance Publications Application.
Data Sources & Contacts
Full trial details
For more Information